April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
Reducing Apoptosis in the Ischemic Retina Using Hyperbaric Oxygen Treatment in Two Different Mouse Models
Author Affiliations & Notes
  • D. Ezrachi
    Ophthalmology, Rabin Medical Center, Petach Tiqwa, Israel
  • V. Gaydar
    The Krieger Eye Research Laboratory, FMRC, Rabin Campus, Sackler School of Medicine, Tel Aviv University, Petach Tiqwa, Israel
    The Mina and Everard Goodman Faculty of Life Sciences, Bar Ilan University, Ramat Gan, Israel
  • S. Hofstetter
    The Krieger Eye Research Laboratory, FMRC, Rabin Campus, Sackler School of Medicine, Tel Aviv University, Petach Tiqwa, Israel
  • B. R. Avraham-Lubin
    The Krieger Eye Research Laboratory, FMRC, Rabin Campus, Sackler School of Medicine, Tel Aviv University, Petach Tiqwa, Israel
  • O. Dratviman-Storobinsky
    The Krieger Eye Research Laboratory, FMRC, Rabin Campus, Sackler School of Medicine, Tel Aviv University, Petach Tiqwa, Israel
    The Mina and Everard Goodman Faculty of Life Sciences, Bar Ilan University, Ramat Gan, Israel
  • N. Goldenberg-Cohen
    The Krieger Eye Research Laboratory, FMRC, Rabin Campus, Sackler School of Medicine, Tel Aviv University, Petach Tiqwa, Israel
    Ophthalmology, Pediatric Unit, Schneider Children's Medical Center of Israel, Petach Tiqwa, Israel
  • Footnotes
    Commercial Relationships  D. Ezrachi, None; V. Gaydar, None; S. Hofstetter, None; B.R. Avraham-Lubin, None; O. Dratviman-Storobinsky, None; N. Goldenberg-Cohen, None.
  • Footnotes
    Support  The Zanvyl and Isabelle Krieger Fund, Baltimore, MD
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 687. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      D. Ezrachi, V. Gaydar, S. Hofstetter, B. R. Avraham-Lubin, O. Dratviman-Storobinsky, N. Goldenberg-Cohen; Reducing Apoptosis in the Ischemic Retina Using Hyperbaric Oxygen Treatment in Two Different Mouse Models. Invest. Ophthalmol. Vis. Sci. 2009;50(13):687.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Methods: : Mice underwent CRAO (n=40) or crush induction (n=40); 20 of each group underwent HBO treatment. CRAO was induced by laser activation after rose-Bengal administration intravenously. Crush injury was induced by compressing the optic nerve posterior to the globe. Mice treated by HBO were exposed to 100% oxygen, in 2 atm for 90 minutes immediately after induction, and daily thereafter for up to 14 days. Histological sections of the retina were examined for apoptosis; mRNA expression levels of Bax, Bcl-2, and Caspase-3 were analyzed using quantitative real-time PCR, in the treated and untreated induced ischemic retinae.

Results: : Maximal retinal cell loss of the inner retinal layers on day 21 were 60% and 80% in the CRAO and crush injury respectively. In the HBO treated groups, cell loss was only 30% and 40% respectively. Molecular analysis revealed an increase of Bax (X4), Caspase 3 (X2) and Bcl-2 (X1.5) on day 1 in crush models, but not in the HBO treated mice. On day 3 all levels reverted to baseline (Caspase 3, Bax) or lower (Bcl-2 0.67), similar to the levels measured in the HBO treated mice. CRAO showed similar trends, with 2-fold increase in the Bcl-2 level on day 3 in the HBO treated group.

Conclusions: : HBO-treatment protects neuronal cells from apoptosis. Histologically and molecularly we demonstrated reduced apoptosis and tissue preservation. These results encourage further clinical trials in patients with ischemic neuronal damage.

Keywords: apoptosis/cell death • ischemia • retina 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×